$LQDT

Liquidity Services (NASDAQ:LQDT) Insider Novelette Murray Sells 6,176 Shares

Liquidity Services insider Novelette Murray sold 6,176 shares on May 22 at an average $34.16, for about $210,972, according to an SEC filing. After the sale, she directly owned 35,769 shares. The stock trades around $36.06 after opening Thursday; it reported Q1 EPS of $0.35 on May 7.

Original reporting
Published May 28, 2026, 11:00 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 28, 2026, 11:43 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Liquidity Services (NASDAQ:LQDT) Insider Novelette Murray Sells 6,176 Shares — source image
Decision brief

The 30-second read

$LQDTBearishMed
01

Why it matters

The actionable element is the disclosed insider sale size and price, which can influence short-term sentiment even without new operating fundamentals.

02

Market read

Traders may reassess near-term sentiment toward LQDT given insider selling, but should balance it against the recent earnings beat and cited institutional buying.

03

What to watch

The article also cites multiple institutional investors increasing stakes; traders may weigh these flows more than insider selling when forming near-term bias.

Relevance 7/10Novelty 6/10Timing: after SEC insider sale disclosure (transaction dated May 22)

Background

The piece is an insider transaction update (SEC-disclosed) for Liquidity Services, alongside a recap of recent earnings and analyst commentary.

Company-level read

Ticker impact

$LQDTBearishMedium confidence
Context

Liquidity Services insider Novelette Murray sold 6,176 shares at $34.16, reducing her stake by 14.72% per SEC filing.

Expected impact

Likely limited downside bias intraday-to-near term unless additional insider sales or guidance changes emerge.

Evidence & confidence

The article provides a specific Form 4-style sale (price, size, and post-transaction holdings) alongside recent earnings beat and institutional inflow mentions, which can offset pure sentiment effects.

Market effects

No direct sector catalyst; this is company-specific ownership/positioning information for an online surplus/remarketing marketplace.

None indicated.

None indicated.

Counterpoint

Insider sales can be routine (tax/portfolio diversification) and the company recently reported EPS above consensus, reducing the signal strength of a single sale.

Key entities

  • Liquidity Services, Inc.

    Subject of the insider sale disclosure and recent earnings/guidance recap.

  • Novelette Murray

    Insider who sold 6,176 shares at an average $34.16, cutting her position by 14.72%.

Related articles

$LQDTMed

Liquidity Services Targets $2B GMV Through GovDeals, Machinio Expansion

Liquidity Services (NASDAQ:LQDT) aims to reach $2B in GMV through expansions of GovDeals and Machinio. The company expects mid-teens revenue growth and 20%+ EBITDA margins. It is debt-free with $200M+ in cash and targets $100M in EBITDA. Liquidity Services is exploring acquisitions and new services, including real estate sales and a direct-to-consumer auction platform.

$LQDTMedAI 8/10

Liquidity Services (LQDT) Q3 2026 Earnings Call Transcript

Liquidity Services (LQDT) reported Q3 FY2026 results on an earnings call. GMV rose 10% to $453.0 million and revenue increased 8% to $129.6 million. GAAP net income was $10.4 million, up 41%, and GAAP diluted EPS was $0.32. Q4 guidance: GMV $415m to $455m, adjusted EBITDA $22m to $25m, GAAP EPS $0.30 to $0.39.

$LQDTMed

LIQUIDITY SERVICES INC (LQDT): Results of Operations and Financial Condition

LIQUIDITY SERVICES INC (LQDT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 LIQUIDITY SERVICES ANNOUNCES THIRD QUARTER FISCAL YEAR 2026 FINANCIAL RESULTS Share Expansion, Platform Efficiencies and Strong Buyer Participation Drive Profitable Growth Bethesda, MD - August 6, 2026 - Liquidity Services (NASDAQ:LQDT; www.liquidityservices.com), th

$BNTXMed

BioNTech Ended a Cancer Vaccine Trial. What Does it Mean for its mRNA Strategy?

BioNTech (NASDAQ:BNTX) halted a mid-stage trial of its mRNA cancer vaccine, autogene cevumeran, due to an overall survival imbalance. The decision raises concerns about its mRNA strategy in colorectal cancer and other 'cold' tumors. BioNTech plans to continue other trials, including one for pancreatic cancer and BNT113 for head and neck cancer. The company also focuses on diversifying its oncology pipeline. According to Reuters, the news caused a 7.5% drop in BioNTech's US-listed shares.

$VOW3.DEMed

HISTORIC TURN: Volkswagen To Produce Components For Israel’s Iron Dome System In Germany

Volkswagen (VW) plans to produce components for Israel's Iron Dome missile defense system at its Osnabrück, Germany factory. The move is part of VW's restructuring efforts amid economic challenges and competition. The project involves a joint venture with Israeli defense company Rafael and the German state of Lower Saxony, aiming to overcome opposition from Qatar's sovereign wealth fund, a VW stakeholder. This marks VW's return to defense-related manufacturing as European defense spending rises.